- Home
- DSGR vs CLDX Comparison
DSGR vs CLDX Comparison
Compare DSGR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGR
- CLDX
- Stock Information
- Founded
- DSGR 1952
- CLDX N/A
- Country
- DSGR United States
- CLDX United States
- Employees
- DSGR N/A
- CLDX N/A
- Industry
- DSGR Industrial Machinery/Components
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DSGR Industrials
- CLDX Health Care
- Exchange
- DSGR Nasdaq
- CLDX Nasdaq
- Market Cap
- DSGR 1.4B
- CLDX 1.3B
- IPO Year
- DSGR N/A
- CLDX 2008
- Fundamental
- Price
- DSGR $28.60
- CLDX $17.38
- Analyst Decision
- DSGR Buy
- CLDX Buy
- Analyst Count
- DSGR 2
- CLDX 8
- Target Price
- DSGR $43.00
- CLDX $54.29
- AVG Volume (30 Days)
- DSGR 52.1K
- CLDX 776.1K
- Earning Date
- DSGR 05-01-2025
- CLDX 05-05-2025
- Dividend Yield
- DSGR N/A
- CLDX N/A
- EPS Growth
- DSGR N/A
- CLDX N/A
- EPS
- DSGR N/A
- CLDX N/A
- Revenue
- DSGR $1,804,104,000.00
- CLDX $7,020,000.00
- Revenue This Year
- DSGR $14.79
- CLDX N/A
- Revenue Next Year
- DSGR $4.44
- CLDX $27.01
- P/E Ratio
- DSGR N/A
- CLDX N/A
- Revenue Growth
- DSGR 14.88
- CLDX 1.99
- 52 Week Low
- DSGR $27.30
- CLDX $16.46
- 52 Week High
- DSGR $41.47
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- DSGR 44.99
- CLDX 33.94
- Support Level
- DSGR $27.30
- CLDX $19.48
- Resistance Level
- DSGR $28.90
- CLDX $20.38
- Average True Range (ATR)
- DSGR 0.81
- CLDX 1.00
- MACD
- DSGR 0.00
- CLDX -0.21
- Stochastic Oscillator
- DSGR 48.33
- CLDX 20.18
About DSGR Distribution Solutions Group Inc.
Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education, and medical industries.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.